Motilide polymorphs

Details for Australian Patent Application No. 2007330456 (hide)

Owner Pfizer Inc.

Inventors Buchanan, Greg; Eddleston, Mark; Eberlin, Alexander Redvers; Licari, Peter; Galazzo, Jorge

Agent Spruson & Ferguson

Pub. Number AU-B-2007330456

PCT Pub. Number WO2008/068593

Priority 60/873,101 05.12.06 US

Filing date 21 November 2007

Wipo publication date 12 June 2008

Acceptance publication date 3 March 2011

International Classifications

C07H 17/08 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

A61K 31/7048 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/068593 Priority application(s): WO2008/068593

9 July 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Motilide polymorphs

3 March 2011 Application Accepted

  Published as AU-B-2007330456

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007330457-System for concurrent optimization of business economics and customer value

2007330431-Process for increasing the basis weight of sheet materials